cannabis indica

Índice completo — página 16 de 77

Estudos 1.501 a 1.600 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2022 a 2021. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 1.501 a 1.600

  1. 2022

    Treatment of Ovarian Hyperstimulation Syndrome in a Mouse Model by Cannabidiol, an Angiogenesis Pathway Inhibitor

    FavorávelEstudo em AnimaisDorCâncerInflamação+17
  2. 2022

    Trends in Cannabis Use Disorder Diagnoses in the U.S. Veterans Health Administration, 2005-2019

    DesfavorávelMetanáliseDorDependência QuímicaEfeitos Adversos da Cannabis+1
  3. 2022

    TRPV1: A Common Denominator Mediating Antinociceptive and Antiemetic Effects of Cannabinoids

  4. 2022

    UK Medical Cannabis Registry palliative care patients cohort: initial experience and outcomes

    FavorávelMetanáliseDorAnsiedadeDepressão+2
  5. 2022

    UK Medical Cannabis Registry: an analysis of clinical outcomes of medicinal cannabis therapy for generalized anxiety disorder

    FavorávelMetanáliseAnsiedade
  6. 2022

    Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combined with Olfactory Training to Treat Post-COVID-19 Olfactory Impairment: A Multi-Center Double-Blinded Randomized Placebo- Controlled Clinical Trial

    FavorávelEnsaio Clínico Duplo-CegoInflamaçãoCOVID-19Palmitoiletanolamida (PEA)
  7. 2022

    Unexpected improvement of hyperhidrosis with cannabidiol

    FavorávelMetanáliseCâncerAutismoCâncer — Pulmão+1
  8. 2022

    Unexpected short- and long-term effects of chronic adolescent HU-210 exposure on emotional behavior

  9. 2022

    United States Emergency Department Screening for Drug Use Among Assault-Injured Individuals: A Systematic Review

  10. 2022

    United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020

    InconclusivoMetanáliseCâncerAnsiedadeDepressãoAyahuasca+3
  11. 2022

    Unknown risks of psychosis and addiction with delta-8-THC: A call for research, regulation, and clinical caution

    InconclusivoMetanáliseEfeitos Adversos da CannabisPsicoseDelta-8-THC
  12. 2022

    Updates in the use of cannabis for insomnia

    InconclusivoMetanáliseInsônia e Distúrbios do SonoSíndrome das Pernas Inquietas
  13. 2022

    Urinary Cannabis Metabolite Concentrations in Cannabis Hyperemesis Syndrome

  14. 2022

    Urinary Excretion Profile of Cannabinoid Analytes Following Acute Administration of Oral and Vaporized Cannabis in Infrequent Cannabis Users

    InconclusivoEnsaio Clínico Duplo-CegoCanabinol (CBN)Tetraidrocanabivarina (THCV)+1
  15. 2022

    Use of cannabidiol in the treatment of epilepsy

    FavorávelMetanáliseEpilepsia
  16. 2022

    Use of cannabidiol in the treatment of epilepsy: Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex

  17. 2022

    Use of cannabis in the treatment of animals: a systematic review of randomized clinical trials

    FavorávelMetanálise ClínicaDorDor — CrônicaEpilepsia+4
  18. 2022

    Use of Marijuana: Effect on Brain Health: A Scientific Statement From the American Heart Association

    DesfavorávelMetanáliseDisfunção CognitivaAVC
  19. 2022

    Using the BMD Approach to Derive Acceptable Daily Intakes of Cannabidiol (CBD) and Tetrahydrocannabinol (THC) Relevant to Electronic Cigarette Liquids

    InconclusivoMetanáliseTetraidrocanabinol (THC)
  20. 2022

    Validity of self-report measures of cannabis use compared to biological samples among women of reproductive age: a scoping review

  21. 2022

    Variations of cannabis-related adverse mental health and addiction outcomes across adolescence and adulthood: A scoping review

  22. 2022

    Viphyllin TM, a Standardized Black Pepper Seed Extract Exerts Antinociceptive Effects in Murine Pain Models via Activation of Cannabinoid Receptor CB2, Peroxisome Proliferator-Activated Receptor-Alpha and TRPV1 Ion Channels

    FavorávelEstudo em AnimaisDorDor — Aguda
  23. 2022

    Vitamin D mitigates diabetes-associated metabolic and cognitive dysfunction by modulating gut microbiota and colonic cannabinoid receptor 1

    FavorávelEstudo em AnimaisDisfunção CognitivaObesidadeDiabetesMicrobioma+2
  24. 2022

    What Do We Know About Medical Cannabis in Neurological Disorders and What Are the Next Steps?

  25. 2022

    Who mixes tobacco with cannabis and does mixing relate to nicotine dependence?

    DesfavorávelMetanáliseDependência QuímicaDependência — Nicotina
  26. 2022

    Why Do Marijuana and Synthetic Cannabimimetics Induce Acute Myocardial Infarction in Healthy Young People?

  27. 2022

    Why Do Some People Become More Involved in Cannabis Use Than Others? A Systematic Narrative Review on Cannabis Use Transition Predictors

  28. 2022

    Will Cannabigerol Trigger Neuroregeneration after a Spinal Cord Injury? An In Vitro Answer from NSC-34 Scratch-Injured Cells Transcriptome

  29. 2022

    β-Caryophyllene promotes oxidative stress and apoptosis in KB cells through activation of mitochondrial-mediated pathway - An in-vitro and in-silico study

    FavorávelEstudo LaboratorialCâncerInflamação
  30. 2022

    β-Caryophyllene suppresses ferroptosis induced by cerebral ischemia reperfusion via activation of the NRF2/HO-1 signaling pathway in MCAO/R rats

    FavorávelEstudo em AnimaisAVC
  31. 2022

    Δ9-Tetrahydrocannabinol (Δ9-THC) Improves Ischemia/Reperfusion Heart Dysfunction and Might Serve as a Cardioprotective Agent in the Future Treatment

  32. 2021

    "If I knew I could get that every hour instead of alcohol, I would take the cannabis": need and feasibility of cannabis substitution implementation in Canadian managed alcohol programs

    FavorávelMetanáliseDependência QuímicaDependência — Álcool
  33. 2021

    “Is medical cannabis safe for my patients?” A practical review of cannabis safety considerations

    InconclusivoMetanáliseEfeitos Adversos da Cannabis
  34. 2021

    "Less pain with more gain"-Managing wound-related pain with cannabis-based medicines

    FavorávelMetanáliseDorDor — CrônicaCicatrização
  35. 2021

    "Light cannabis" consumption in a sample of young adults: Preliminary pharmacokinetic data and psychomotor impairment evaluation

    FavorávelEnsaio ClínicoDisfunção Cognitiva
  36. 2021

    (+)-trans-Cannabidiol-2-hydroxy pentyl is a dual CB 1 R antagonist/CB 2 R agonist that prevents diabetic nephropathy in mice

    FavorávelEstudo em AnimaisDorDiabetesSíndrome Metabólica+3
  37. 2021

    (+/-)-Borneol Reverses Mitoxantrone Resistance against P-Glycoprotein

    FavorávelEstudo LaboratorialCâncerInfecções Bacterianas
  38. 2021

    (m)RVD-hemopressin (α) and (m)VD-hemopressin (α) improve the memory-impairing effect of scopolamine in novel object and object location recognition tasks in mice

    FavorávelEstudo em AnimaisDoença de AlzheimerCanabinoide Sintético (não especificado)
  39. 2021

    [An unusual allergy : cannabis-fruit and vegetable syndrome]

    FavorávelMetanáliseAlergia à Cannabis
  40. 2021

    [Cannabis and cannabinoids for the treatment of acute and chronic pain]

    InconclusivoMetanáliseDorDor — CrônicaDor — Aguda
  41. 2021

    [Cannabis use among patients with inflammatory bowel disease]

    InconclusivoMetanáliseDorInflamação
  42. 2021

    [Droghe d'abuso e rene] Drugs of Abuse and the Kidney

  43. 2021

    [Efficacy of psychedelics in psychiatry, a systematic review of the literature]

    FavorávelMetanálise ClínicaDependência QuímicaDependência — CannabisAnsiedadeAyahuasca+8
  44. 2021

    [Electronic cigarette use-associated lung injury: a case report and literature review]

    DesfavorávelMetanáliseEfeitos Adversos da CannabisLesão Pulmonar por Vaping (EVALI)
  45. 2021

    1,8-cineole ameliorates ischaemic brain damage via TRPC6/CREB pathways in rats

    FavorávelEstudo em AnimaisAVC
  46. 2021

    A 20-Year-Old Man with e-Cigarette or Vaping Product Use-Associated Lung Injury (EVALI) and Thrombotic Coagulopathy

    DesfavorávelMetanáliseLesão Pulmonar por Vaping (EVALI)
  47. 2021

    A 23-year-old man with acute lung injury after using a tetrahydrocannabinol-containing vaping device: a case report

    DesfavorávelMetanáliseInflamaçãoEfeitos Adversos da CannabisNáusea e Vômito+6
  48. 2021

    A 3-year-old child with multi-drug resistant epilepsy responding to pharmacological and nonpharmacological treatments

    FavorávelMetanáliseEpilepsia
  49. 2021

    A 41-Year-Old Man Presenting With Shortness of Breath, Nausea, Vomiting, and Diarrhea

    DesfavorávelMetanáliseEfeitos Adversos da CannabisAnsiedadeNáusea e Vômito+3
  50. 2021

    A cannabidiol-loaded Mg-gallate metal-organic framework-based potential therapeutic for glioblastomas

    FavorávelEstudo LaboratorialCâncerCâncer — Cérebro
  51. 2021

    A Cannabinoid 2-Selective Agonist Inhibits Allogeneic Skin Graft Rejection In Vivo

  52. 2021

    A cannabinoid type 2 (CB2) receptor agonist augments NOS-dependent responses of cerebral arterioles during type 1 diabetes

    FavorávelEstudo em AnimaisDiabetesCanabinoides Sintéticos JWH-x
  53. 2021

    A cannabis oracle? Delphi method not a substitute for randomized controlled trials of cannabinoids as therapeutics

    DesfavorávelMetanáliseDorDor — Crônica
  54. 2021

    A Change in Blood Carbamazepine Levels Associated With Cannabis Use: Implications for Clinical Practice

  55. 2021

    A clinician survey of use assessment, documentation, and education about cannabis in persons with cystic fibrosis

    InconclusivoMetanáliseFibroseFibrose — Pulmonar
  56. 2021

    A Comparative In Vitro Study of the Neuroprotective Effect Induced by Cannabidiol, Cannabigerol, and Their Respective Acid Forms: Relevance of the 5-HT 1A Receptors

    FavorávelEstudo LaboratorialEstresse OxidativoDoenças NeurodegenerativasCanabigerol (CBG)
  57. 2021

    A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of β-caryophyllene, a dietary cannabinoid

    FavorávelMetanáliseInflamaçãoDoenças Cardiovasculares (DCV)Estresse Oxidativo+1
  58. 2021

    A Functionalized Octahedral Palladium Nanozyme as a Radical Scavenger for Ameliorating Alzheimer's Disease

    FavorávelEstudo em AnimaisEstresse OxidativoDoença de Alzheimer
  59. 2021

    A geospatiotemporal and causal inference epidemiological exploration of substance and cannabinoid exposure as drivers of rising US pediatric cancer rates

  60. 2021

    A latent class analysis of cannabis use products in a general population sample of adolescents and their association with paranoia, hallucinations, cognitive disorganisation and grandiosity

    DesfavorávelEnsaio ClínicoEfeitos Adversos da CannabisAnsiedadePsicose+1
  61. 2021

    A Literature Review of Cannabis and Myocardial Infarction—What Clinicians May Not Be Aware Of

    DesfavorávelMetanáliseDoenças Cardiovasculares (DCV)Infarto
  62. 2021

    A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019

    InconclusivoMetanáliseDorCâncerDor — CrônicaTHC FarmacêuticoCBD Farmacêutico+10
  63. 2021

    A Mini-Review of Relationships Between Cannabis Use and Neural Foundations of Reward Processing, Inhibitory Control and Working Memory

  64. 2021

    A Mobile Phone-Based Life-Skills Training Program for Substance Use Prevention Among Adolescents: Cluster-Randomized Controlled Trial

    FavorávelEnsaio Clínico Duplo-CegoDependência QuímicaDependência — CannabisDependência — Álcool+1
  65. 2021

    A molecular explanation of cardiovascular protection through abnormal cannabidiol: Involving the dysfunctional β-adrenergic and ATP-sensitive K+ channel activity in cardiovascular compromised preterm infants

  66. 2021

    A New Clinical Utility for Tubular Markers to Identify Kidney Responders to Saxagliptin Treatment in Adults With Diabetic Nephropathy

  67. 2021

    A Novel Mechanism of Cannabidiol in Suppressing Hepatocellular Carcinoma by Inducing GSDME Dependent Pyroptosis

    FavorávelEstudo em AnimaisCâncerCâncer — Fígado
  68. 2021

    A pain killer without analgesic tolerance designed by co-targeting PSD-95-nNOS interaction and α2-containning GABA A Rs

    FavorávelEstudo em AnimaisDorDor — Crônica
  69. 2021

    A patient perspective of complementary and integrative medicine (CIM) for migraine treatment: a social media survey

    InconclusivoMetanáliseEnxaquecaMedicina Mente-Corpo
  70. 2021

    A Phase 1 Open-Label, Fixed-Sequence Pharmacokinetic Drug Interaction Trial to Investigate the Effect of Cannabidiol on the CYP1A2 Probe Caffeine in Healthy Subjects

    DesfavorávelEnsaio ClínicoEpilepsiaEpilepsia — Lennox-GastautCBD Farmacêutico
  71. 2021

    A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma

    FavorávelEnsaio Clínico Duplo-CegoCâncerCâncer — CérebroTHC:CBD Farmacêutico
  72. 2021

    A Phase 2 Randomised Clinical Trial Assessing the Tolerability of Two Different Ratios of Medicinal Cannabis in Patients With High Grade Gliomas

    FavorávelEnsaio ClínicoCâncerCâncer — Cérebro
  73. 2021

    A Phase 2 Randomized Controlled Trial of the Efficacy and Safety of Cannabidivarin as Add-on Therapy in Participants with Inadequately Controlled Focal Seizures

    InconclusivoEnsaio Clínico Duplo-CegoEpilepsiaCanabidivarina (CBDV)
  74. 2021

    A phase I trial of the safety, tolerability and pharmacokinetics of cannabidiol administered as single-dose oil solution and single and multiple doses of a sublingual wafer in healthy volunteers

    FavorávelEnsaio ClínicoTHC:CBD Farmacêutico
  75. 2021

    A Phase-2 Pilot Study of a Therapeutic Combination of Δ 9-Tetrahydracannabinol and Palmitoylethanolamide for Adults With Tourette's Syndrome

    FavorávelEnsaio ClínicoTiques e Síndrome de TouretteOutros Compostos Relacionados
  76. 2021

    A pilot randomised placebo-controlled trial of cannabidiol to reduce severe behavioural problems in children and adolescents with intellectual disability

    FavorávelEnsaio Clínico Duplo-CegoDisfunção CognitivaAutismoTDA e TDAH
  77. 2021

    A pilot randomized clinical trial of Brief Behavioral Treatment for Insomnia to reduce problematic cannabis use among trauma-exposed young adults

  78. 2021

    A pilot safety, tolerability and pharmacokinetic study of an oro-buccal administered cannabidiol-dominant anti-inflammatory formulation in healthy individuals: a randomized placebo-controlled single-blinded study

    InconclusivoEnsaio ClínicoInflamação
  79. 2021

    A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats

    InconclusivoEnsaio ClínicoAnsiedadeDepressãoAyahuasca
  80. 2021

    A potential role for cannabichromene in modulating TRP channels during acute respiratory distress syndrome

  81. 2021

    A primer on medicinal cannabis safety and potential adverse effects

  82. 2021

    A randomized controlled trial of a therapeutic relational agent for reducing substance misuse during the COVID-19 pandemic

    FavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisAnsiedade+3
  83. 2021

    A randomized trial of medical cannabis in patients with stage IV cancers to assess feasibility, dose requirements, impact on pain and opioid use, safety, and overall patient satisfaction

    FavorávelEnsaio ClínicoDorDependência — OpioidesDor — Oncológica
  84. 2021

    A Rare Case of Vaping-Induced Spontaneous Pneumomediastinum

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisDoenças Cardiovasculares (DCV)+4
  85. 2021

    A Reason to Rethink Fasting Guidelines? Marijuana-Induced Gastroparesis and the Implications for Aspiration Risk in the Nil Per Os (NPO) Patient: A Case Report

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisNáusea e Vômito+2
  86. 2021

    A Research Domain Criteria Approach to Gambling Disorder and Behavioral Addictions: Decision-Making, Response Inhibition, and the Role of Cannabidiol

  87. 2021

    A Review of Hemp as Food and Nutritional Supplement

    FavorávelMetanáliseAnsiedadeEpilepsiaEstresse Oxidativo+3
  88. 2021

    A Review of the Current Evidence Connecting Seborrheic Dermatitis and Parkinson's Disease and the Potential Role of Oral Cannabinoids

    FavorávelMetanáliseInflamaçãoDoenças NeurodegenerativasDoença de Parkinson+1
  89. 2021

    A Review of the Potential Use of Pinene and Linalool as Terpene-Based Medicines for Brain Health: Discovering Novel Therapeutics in the Flavours and Fragrances of Cannabis

    FavorávelMetanáliseInflamaçãoAnsiedadeDepressão+6
  90. 2021

    A review on the traditional uses, phytochemistry, and pharmacological activities of clove basil (Ocimum gratissimum L.)

    FavorávelMetanáliseInflamaçãoEpilepsiaInfecções Bacterianas
  91. 2021

    A Role for Peripheral Anandamide and 2-Arachidonoylglycerol in Short-Term Food Intake and Orexigenic Hypothalamic Responses in a Species with Continuous Nutrient Delivery

  92. 2021

    A scoping review of the use of cannabidiol in psychiatric disorders

    FavorávelMetanálise ClínicaDependência — CannabisAnsiedadePsicose+5
  93. 2021

    A scoping review on the effect of cannabis on pain intensity in people with spinal cord injury

    InconclusivoMetanáliseLesões da Medula Espinhal
  94. 2021

    A secondary approach with conventional medicines and supplements to recuperate current COVID-19 status

    FavorávelMetanáliseCOVID-19
  95. 2021

    A single oral dose of cannabidiol did not reduce upper limb tremor in patients with essential tremor

    InconclusivoEnsaio Clínico Duplo-CegoEsclerose MúltiplaDoença de ParkinsonDistonia+1
  96. 2021

    A standardized black pepper seed extract containing β-caryophyllene improves cognitive function in scopolamine-induced amnesia model mice via regulation of brain-derived neurotrophic factor and MAPK proteins

    FavorávelEstudo em AnimaisDisfunção Cognitiva
  97. 2021

    A study of abnormal cannabidiols system-mediated cardiovascular protection in disrupted gut/brain axis associated depression

  98. 2021

    A Survey of Cannabis Use in a Large US-Based Cohort of People with Multiple Sclerosis

    InconclusivoMetanáliseDorAnsiedadeDor — Crônica+2
  99. 2021

    A Survey on the Effect That Medical Cannabis Has on Prescription Opioid Medication Usage for the Treatment of Chronic Pain at Three Medical Cannabis Practice Sites

    FavorávelMetanáliseDorDor — CrônicaDependência — Opioides
  100. 2021

    A systematic review and meta-analysis of cannabis-based medicines, cannabinoids and endocannabinoid system modulators tested for antinociceptive effects in animal models of injury-related or pathological persistent pain